Developing a medical device-grade T2 phantom optimized for myocardial T2 mapping by cardiovascular magnetic resonance
Constantin‐Cristian Topriceanu(University College London), Gabriella Captur(Royal Free London NHS Foundation Trust), Iain Pierce(University College London), Han Gil Seo(Royal Free London NHS Foundation Trust), Peter Kellman(National Institutes of Health), Reza Nezafat(Beth Israel Deaconess Medical Center), Bernd Ittermann(Physikalisch-Technische Bundesanstalt), Rüdiger Bruehl(Physikalisch-Technische Bundesanstalt), Wenjie Pang(Resonance Health (Australia)), Alun D. Hughes(Aberystwyth University), Kirsty Price(Bury College), Louise McGrath(Bury College), Kathryn E. Keenan(National Institute of Standards and Technology), Massimiliano Fornasiero(University College London), Karl F. Stupic(National Institute of Standards and Technology), Matthew Webber(Wellington Hospital), James Moon(University of Michigan)
Cited by 6
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
|Journal of Cardiovascular Magnetic Resonance|2013|1.1k
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
|Circulation|2005|978
Highly conductive, stretchable and biocompatible Ag–Au core–sheath nanowire composite for wearable and implantable bioelectronics
|Nature Nanotechnology|2018|967
A perspective of polyamine metabolism
|Biochemical Journal|2003|927